Loading…

Loading grant details…

Completed H2020 European Commission

Super resolution imaging of nanoPMOs for cancer drug delivery

€184.7K EUR

Funder European Commission
Recipient Organization Centre National de la Recherche Scientifique CNRS
Country France
Start Date Jan 04, 2021
End Date Jan 03, 2023
Duration 729 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 887089
Grant Description

In recent years, nanomaterial-based various drug delivery carriers have been developed for the potential targeted cancer therapy.

However, still the advanced study for optimization of size, shape, surface chemistry of the nanocarrier and observation of biological interaction and evaluation of such nanocarrier are not well-developed that limit their use for the efficient clinical applications.

Therefore, superior understandings of the cellular interaction of the nanocarrier with different physicochemical properties are essential and challenging for improved the cancer treatments.

In this project, we will focus on the optimization of different physicochemical properties of nanocarrier such as size, shape, surface chemistry and etc via investigation of its biological interaction and evaluation by a potent imaging technique.

For this purpose, we will synthesize a library of efficient biodegradable drug delivery carrier periodic mesoporous organosilica nanoparticles (nanoPMOs) withcontrolled size and shape and then functionalized with different targeting ligands with the controlled number per nanoparticle for mannose-6-phosphate receptor over-expressed prostate cancer.

Then we will study the nanoPMOs-prostate cancer cell interactions, internalization pathway and intracellular degradation of nanoPMOs through the stochastic optical reconstruction microscopy (STORM).

We will further evaluate the drug delivery efficacy of nanoPMOs and toxicity mechanism of drug loaded nanoPMOs to support microscopic observation.

Thus the result of this biological interaction and evaluation of nanoPMOs with different physicochemical properties via super-resolution microscope STORM will help to develop a novel drug delivery carrier for prostate cancer therapy with optimal properties for clinical applications.

All Grantees

Centre National de la Recherche Scientifique CNRS

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant